custom array designing
Sitemap | Connect with us:   GenArrays facebook GenArrays twitter GenArrays linkdin GenArrays linkdin
custom array designing
Core Services

Blogs

ArrayGen > Blogs

Growing Next Generation Sequencing Market is expected to reach USD 20.6 Bn by 2025.

Next Generation Sequencing is responsible for massive changes in the sequencing process by providing better output, higher speed, flexibility and reducing the sequencing cost to a higher extent. Due to cost-effectiveness, unprecedented sequencing speed, high resolution, accuracy in genomic analyses and technological developments in the next generation sequencing market are expected to enable researchers to generate phase resolved HLA sequences in single read cycles and provide insight into the lesser accessible regions of HLA genes. Also, prenatal genome sequencing enabled us to detect the genetic anamolies in fetus. Increased use of NGS to develop biopharmaceuticals and drugs for the cure of growing cancer incidences as well as the infectious diseases are further expected to drive demand for next generation sequencing. The market was valued at USD 3.7 Bn in 2017, and is expected to reach USD 20.6 Bn by 2025, expanding at a CAGR of 21.5% from 2017 to 2025.

For further reference click here:

http://www.abnewswire.com/pressreleases/next-generation-sequencing-market-future-demand-growth-analysis-and-forecast-to-2025-acute-market-reports_164585.html?utm_source=dlvr.it&utm_medium=twitter


Market Forecast 2017-2027: Next Generation Sequencing .

Visiongain's 248-page report on Next Generation Sequencing provides 192 tables, charts, and graphs showing you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

In addition to revenue forecasting to 2027, this new study provides us with recent results, growth rates, and market shares, original analyses, with business outlooks and developments. And we can discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Let us discover sales predictions for the world market and submarkets along with revenue prediction for the overall world market, 4 segmentations of the Next Generation Sequencing market, with forecasts for 7 Applications, 8 Technologies, 3 Product Types and 5 End Users, each forecasted at a global and regional level.

The report could be found here:

https://www.prnewswire.com/news-releases/the-next-generation-sequencing-market-forecast-2017-2027-300562958.html


NGS opens the door for drug discovery.

Next-Generation Sequencing could be used for generation of large datasets, which can be mined for the identification of novel targets for drug discovery. Identification of potential targets for novel antimicrobials when sequencing collections of bacterial isolates could be a potential example of this. Using Illumina sequencing allows the rapid generation of a large number of bacterial genomes from a single sequencing run. NGS can also be used to support the later stages of drug discovery, such as clinical trials. Next-generation sequencing has the potential to enable further exploration of people’s genomes.

The report could be found here:

https:https://www.drugtargetreview.com/article/25719/next-generation-sequencing-drug-discovery/

“WHO” issues rapid communication on use of targeted next-generation sequencing for diagnosis of drug-resistant tuberculosis (25th July 2023).

Gevana Targeted next generation sequencing for detection of drug resistant TB is the new class of diagnostic technology, which provide accurate and rapid data analysis of genetic material and detection of mutations associated with resistance a fraction of time for cultured based methods for detecting resistance. Detection of all categories of drug-resistant TB remains a challenge and more comprehensive drug susceptibility testing solutions are needed. The introduction of new drugs and repurposing of existing drugs for the treatment of TB and drug-resistant TB have generated new regimens at a rapid rate, improving treatment options, outcomes, and quality of life for individuals with TB. However, as resistance even to these new and repurposed drugs gradually increases, better diagnostic options for rapid diagnosis of drug-resistant TB are needed. WHO’s Global TB Programme convened a Guideline Development Group meeting between 2-5 May 2023 to review the available evidence on the use of targeted NGS solutions and make recommendations on their clinical use in detecting drug resistant TB.

The report could be found here:

https://www.who.int/news/item/25-07-2023-who-issues-rapid-communication-on-use-of-targeted-next-generation-sequencing-for-diagnosis-of-drug-resistant-tuberculosis

Chinese Multiomics Study Elucidates Aging Process in Women (28th July 2023).

By bringing together multiomic data for all age women, a team from the Chinese Academy of Sciences and other centers in China like Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Center for Quantitative Biology (CQB), Peking University, Beijing, 100871, China Key Laboratory of Computational Biology, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China have developed more than a dozen "aging clocks" reflecting the process of aging in specific tissues like bone, cartilage, and smooth muscle or body parts, molecular systems, the immune system, and the whole body. The team used RNA sequencing, mass spectrometry, and 16S rRNA gene sequencing to track transcriptomic, proteomic, metabolomic, and gut microbiome patterns in plasma, peripheral blood mononuclear cell, or stool samples from 113 healthy female participants from China, who ranged in age from 20 to 66 years. The investigators also turned to single-cell RNA sequencing to assess transcriptome profiles in samples from a subset of 12 individuals.

The report could be found here: Peking-Tsinghua centre for lifesciences, Academy for Advanced Interdi:

https://www.genomeweb.com/

 
 
 
Archaea
Bacteria
Eukaryota
Home
About Us
FAQs
Careers
Contact Us
Sitemap
Terms & Conditions
ArrayGen Technologies Pvt. Ltd.
VTP Trade Park, Wing 4, Office No 237, Second Floor, URBAN NEST,
Shree Siddhivinayak Meera, Undri,
Pune-411060, Maharashtra
Phone No. :: +91 20-67026274
Mobile No :: +91 9673625446
Skype :: arraygen
E-mail :: info@arraygen.com

Leave this empty:



 
© 2015 ArrayGen Technologies Pvt. Ltd. All Rights Reserved.